Thomas M A, Rebar R W, LaBarbera A R, Pennington E J, Liu J H
Department of Obstetrics and Gynecology, University of Cincinnati College of Medicine, Ohio 45267.
J Clin Endocrinol Metab. 1991 Jun;72(6):1249-54. doi: 10.1210/jcem-72-6-1249.
Acute activation of the hypothalamic-pituitary axis with CRH has been reported to suppress gonadotropin secretion in women of reproductive age. In this study we specifically examined the effects of increasing doses of human CRH (hCRH) on circulating concentrations of ACTH, cortisol, and gonadotropins in five agonadal women, aged 46-65 (mean, 51.2) yr. The subjects had undergone either natural menopause or surgical removal of their ovaries at least 1 yr before study. Each woman was studied on four separate occasions and received either saline or hCRH at a dose of 0.5, 1.0, or 2.0 micrograms/kg BW through an indwelling iv catheter in a randomized, single blind fashion. During each experiment, five sequential iv injections of the same dose of hCRH or saline were administered at 90-min intervals over an 8-h period, followed by a 10-micrograms iv bolus of GnRH to test for pituitary gonadotropin responsiveness. Blood samples for measurement of LH, FSH, PRL, ACTH, and cortisol were obtained at 15-min intervals through an indwelling iv in the contralateral arm. Episodic pulses of LH secretion were analyzed using the Cluster computer program. Transverse mean LH, FSH, and PRL levels did not change with increasing hCRH doses. Mean (+/- SEM) LH pulse frequency [saline, 5.2 +/- 0.4/8 h; hCRH, (0.5 micrograms/kg), 4.8 +/- 0.2; hCRH (1 microgram/kg), 5.2 +/- 0.2; hCRH (2 micrograms/kg), 5.4 +/- 0.2] and amplitude [saline, 14.4 +/- 4.2 IU/L; hCRH (0.5 microgram/kg), 14.0 +/- 2.4; hCRH (1 microgram/kg), 15.8 +/- 2.5; hCRH (2 micrograms/kg), 17.2 +/- 2.9] did not differ among groups. Although the transverse mean levels of ACTH [saline, 8.7 +/- 0.2 pmol/L; hCRH (0.5 microgram/kg), 12.4 +/- 0.3; hCRH (1 microgram/kg), 11.5 +/- 0.4; hCRH (2 micrograms/kg), 12.8 +/- 0.4] did not change with increasing doses of hCRH, the duration of cortisol peaks after hCRH was longer and accounted for the increased transverse mean at each dose [saline, 152.8 +/- 4.1 nmol/L; hCRH (0.5 microgram/kg), 265.4 +/- 10.5; hCRH (1 microgram/kg), 329.7 +/- 14.3; hCRH (2 micrograms/kg), 348.2 +/- 12.1]. These findings suggest that ever larger doses of pulsatile hCRH continue to increase adrenal output of cortisol secondary to more sustained ACTH responses. However, hCRH-induced acute hypercortisolism does not alter gonadotropin secretion in agonadal women.
据报道,用促肾上腺皮质激素释放激素(CRH)急性激活下丘脑-垂体轴可抑制育龄期女性的促性腺激素分泌。在本研究中,我们专门研究了递增剂量的人促肾上腺皮质激素释放激素(hCRH)对5名年龄在46 - 65岁(平均51.2岁)的性腺功能缺失女性体内促肾上腺皮质激素(ACTH)、皮质醇和促性腺激素循环浓度的影响。这些受试者在研究前至少1年已自然绝经或接受了卵巢手术切除。每位女性在4个不同时间接受研究,通过留置静脉导管以随机、单盲方式接受生理盐水或剂量为0.5、1.0或2.0微克/千克体重的hCRH。在每个实验期间,在8小时内每隔90分钟静脉注射5次相同剂量的hCRH或生理盐水,随后静脉推注10微克促性腺激素释放激素(GnRH)以测试垂体促性腺激素反应性。通过对侧手臂的留置静脉每隔15分钟采集血样以测量促黄体生成素(LH)、促卵泡生成素(FSH)、催乳素(PRL)、ACTH和皮质醇。使用Cluster计算机程序分析LH分泌的间歇性脉冲。随着hCRH剂量增加,LH、FSH和PRL的横向平均水平未发生变化。平均(±标准误)LH脉冲频率[生理盐水组,5.2±0.4次/8小时;hCRH(0.5微克/千克)组,4.8±0.2次;hCRH(1微克/千克)组,5.2±0.2次;hCRH(2微克/千克)组,5.4±0.2次]和幅度[生理盐水组,14.4±4.2国际单位/升;hCRH(0.5微克/千克)组,14.0±2.4国际单位/升;hCRH(1微克/千克)组,15.8±2.5国际单位/升;hCRH(2微克/千克)组,17.2±2.9国际单位/升]在各组之间无差异。尽管随着hCRH剂量增加,ACTH的横向平均水平[生理盐水组,8.7±0.2皮摩尔/升;hCRH(0.5微克/千克)组,12.4±0.3皮摩尔/升;hCRH(1微克/千克)组,11.5±0.4皮摩尔/升;hCRH(2微克/千克)组,12.8±0.4皮摩尔/升]未发生变化,但hCRH后皮质醇峰值的持续时间更长,这导致了每个剂量下横向平均值的增加[生理盐水组,152.8±4.1纳摩尔/升;hCRH(0.5微克/千克)组,265.4±10.5纳摩尔/升;hCRH(1微克/千克)组,329.7±14.3纳摩尔/升;hCRH(2微克/千克)组,348.2±12.1纳摩尔/升]。这些发现表明,越来越大剂量的脉冲式hCRH由于更持久的ACTH反应,会持续增加肾上腺皮质醇的分泌量。然而,hCRH诱导的急性高皮质醇血症不会改变性腺功能缺失女性的促性腺激素分泌。